Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 185

Results For "SEC"

2691 News Found

Digitalization of pharma labs will help in better decision making: Experts
Digitisation | June 02, 2022

Digitalization of pharma labs will help in better decision making: Experts

Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth


PMBI first time ever crossed Rs. 100 crore sales in May, 2022
Policy | June 02, 2022

PMBI first time ever crossed Rs. 100 crore sales in May, 2022

Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024


Govt. launches 2-months long ‘Har Ghar Dastak 2.0’ campaign to expedite Covid-19 vaccination coverage
Policy | June 02, 2022

Govt. launches 2-months long ‘Har Ghar Dastak 2.0’ campaign to expedite Covid-19 vaccination coverage

Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs


DuPont opens new biopharma tubing manufacturing site in US
News | June 02, 2022

DuPont opens new biopharma tubing manufacturing site in US

The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan


ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Drug Approval | June 01, 2022

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children


PAYBACK India announces a strategic partnership with Apollo Pharmacy
News | June 01, 2022

PAYBACK India announces a strategic partnership with Apollo Pharmacy

PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India


USFDA accepts dupilumab for priority review in adults with prurigo nodularis
Drug Approval | June 01, 2022

USFDA accepts dupilumab for priority review in adults with prurigo nodularis

Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved


NATCO launches first generic version of Nexavar Tablets in the US
News | June 01, 2022

NATCO launches first generic version of Nexavar Tablets in the US

The product will be launched by NATCO's commercial partner Viatris.


Novavax initiates phase 3 trial of its COVID-19 omicron booster
Biotech | June 01, 2022

Novavax initiates phase 3 trial of its COVID-19 omicron booster

Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19